Innate Defense RegulatorsInimex Pharmaceuticals, Inc. is a clinical stage company focused on the development and commercialization of Innate Defense Regulators (IDRs), novel first in class drugs that selectively trigger the body’s innate defenses without causing...
Total money raised: $26.5M
Phone: (604) 225-2251
Inimex Pharmaceuticals at CrunchBase
Martin (Marty) McConnell CFO
Oreola Donini Senior Director
Inimex Pharmaceuticals raised $22M in a Series B round from Canadian Medical Discoveries Fund, Astellas Venture Management, Morningside Group, Roche Venture Fund, BC Advantage Funds, Discovery Capital, BDC Venture Capital, and GrowthWorks Capital